Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly Stock Back In Focus After Long Slumber
05:07pm, Friday, 09'th Jan 2026
Here's how we employ swing trading strategies of selling into strength, selling into weakness and cutting a loss quickly.
Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences
01:46pm, Friday, 09'th Jan 2026
Highly rated Eli Lilly stock is this week's Big Cap 20 pick to watch as it attempts to take out a flat-base buy point.
Aktis Oncology Jumps 27% After $318 Million Upsized IPO
01:24pm, Friday, 09'th Jan 2026
Aktis Oncology Inc. (AKTS) drew strong investor demand in its Nasdaq debut, with shares trading at $22.91 as of 12:19 p.m. Friday in New York after pricing its
Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets
12:58pm, Friday, 09'th Jan 2026
LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology compa
Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery
09:00am, Friday, 09'th Jan 2026
SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suite for molecules, announces Eli Lilly and Company collaboration.
First Look: GM's $7.1B EV Charge, Paramount's $30 WBD Bid
07:38am, Friday, 09'th Jan 2026
Stock News xAI under fire over Grok image edits: Elon Musk's xAI (private) restricted Grok's image generation/editing on X to paying users after the tool was us
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software
07:04am, Friday, 09'th Jan 2026
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
06:54am, Friday, 09'th Jan 2026
Abivax stock rallied in 2025, far outpacing peers, as the French biotech surprised investors with a stellar data readout in July for its lead asset – an ulcerative colitis medicine. Now, analysts sa
CX Institutional Purchases 2,191 Shares of Eli Lilly and Company $LLY
04:50am, Friday, 09'th Jan 2026
CX Institutional lifted its holdings in Eli Lilly and Company (NYSE: LLY) by 7.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 30,908 shares of t
Childress Capital Advisors LLC Raises Stock Position in Eli Lilly and Company $LLY
04:50am, Friday, 09'th Jan 2026
Childress Capital Advisors LLC increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 24.1% in the undefined quarter, according to the company in its most recent 13F filing with the
NEW YORK and NEW ORLEANS, Jan. 8, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Market Today: GM's $7B EV Reset, Defense Stocks Pop, Hyundai's Robot Push
05:35pm, Thursday, 08'th Jan 2026
Stock News Silicon Valley split on CA wealth tax: Alphabet's cofounders moved assets out of California while Nvidia's Jensen Huang said he's âperfectly fineâ
Lilly's Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial
02:17pm, Thursday, 08'th Jan 2026
Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis treatment Taltz, improved arthritis symptoms and drove weight loss better than Tal
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Ventyx Biosciences, Inc. (VTYX)
11:44am, Thursday, 08'th Jan 2026
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - January 8, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Ventyx Biosciences,
First Look: Apple-JPM card deal, Ford L3, defense clampdown
07:38am, Thursday, 08'th Jan 2026
Stock News Trump targets Wall Street homebuying: President Trump proposed banning large institutional investors from purchasing single-family homes, sending sha
